Clinical Trials Browser

Phase 4 × Fibrosis × 30 days × Clear all

NCT03520660 2026-03-11

People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents

Phase 4 Active not recruiting

Gastrointestinal

Cardiovascular Diseases, Diabetes Mellitus, Fibrosis, Hepatitis C, Carcinoma, Hepatocellular, Hepatitis C, Chronic